Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and efficacy of GEC255, a novel KRASG12C inhibitor, in advanced solid tumors

被引：0
|
作者：
Zhang, Yan
Zhou, Lin
Gong, Youling
Huang, Meijuan
Tang, Min
Liu, Yongmei
Yu, Min
Xiu, Weigang
Liang, Xinjun
Liu, Xinyu
Fu, Xin-Yuan
Lu, You
机构：
[1] Sichuan Univ, Dept Thorac Oncol, Canc Ctr, West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Thorac Oncol Ward, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China
[4] West China Hosp, Sch Med, Dept Thorac Oncol, Canc Ctr, Chengdu, Peoples R China
[5] Hubei Canc Hosp, Dept Med Oncol, Wuhan, Peoples R China
[6] GenEros Biopharma Ltd, Clin Dev Dept, Hangzhou, Peoples R China
[7] Sichuan Univ, Inst Human Dis & Immunotherapy, West China Hosp, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9112
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Safety, PK and preliminary efficacy of talazoparib in Japanese patients with advanced solid tumors; Phase 1 Study
    Naito, Yoichi
    Kuboki, Yasutoshi
    Ikeda, Masafumi
    Harano, Kenichi
    Matsubara, Nobuaki
    Toyoizumi, Shigeyuki
    Oishi, Masayo
    Hori, Natsuki
    Nagasawa, Takashi
    Kogawa, Takahiro
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Population Pharmacokinetics of Sotorasib in Healthy Subjects and Advanced Solid Tumor Patients Harboring a KRASG12C Mutation from Phase 1 and Phase 2 Studies
    Nagase, Mario
    Houk, Brett
    Vuu, Irene
    Cardona, Panli
    Dutta, Sandeep
    Lin, Chih-Wei
    AAPS JOURNAL, 2025, 27 (01):
  • [23] A phase I study evaluating the safety, efficacy, pharmacokinetics and pharmacodynamics of AL3810 in advanced solid tumors
    Cao, J.
    Li, J.
    Ji, D.
    Shen, W.
    Jiang, L.
    Ma, X.
    Pang, J.
    Kanehisa, A.
    Legrand, F.
    Pallis, A.
    Paux, G.
    Robert, R.
    Chen, X.
    Letecheur, P.
    Qiang, L.
    Ding, J.
    ANNALS OF ONCOLOGY, 2015, 26 : 37 - 37
  • [24] A phase 1b study evaluating the safety and pharmacokinetics (PK) of regorafenib (REG) in combination with cetuximab (CTX) in patients with advanced solid tumors
    Weekes, C.
    Lockhart, A. C.
    Lenz, H-J.
    Lee, J. J.
    Cleton, A.
    Huang, F.
    Sturm, I.
    ANNALS OF ONCOLOGY, 2017, 28
  • [25] A phase 1 study evaluating the safety, pharmacokinetics, and efficacy of fadraciclib, an oral CDK2/9 inhibitor, in patients with advanced solid tumors and lymphoma.
    Villalona-Calero, Miguel Angel
    Oh, Do-Youn
    Garralda, Elena
    Vieito, Maria
    Huang, Julius
    Piha-Paul, Sarina A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRASG12C mutation.
    Pant, Shubham
    Yaeger, Rona
    Spira, Alexander I.
    Pelster, Meredith
    Sabari, Joshua K.
    Hafez, Navid
    Barve, Minal A.
    Velastegui, Karen
    Yan, Xiaohong
    Der-Torossian, Hirak
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [27] A novel oral microtubule inhibitor utidelone capsule (UTD2): A phase 1 clinical study to assess the tolerability, safety, and efficacy in advanced solid tumors
    Wang, Judy S.
    Van Tine, Brian Andrew
    Patel, Manish R.
    Hanna, Diana L.
    Tang, Li
    Qiu, Rongguo
    Guan, Jin
    Thomas, Jacob Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] A phase 1 dose escalation with expansion study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of AMV564 in subjects with advanced solid tumors
    Kairm, Raghad Abdul
    Tolcher, Anthony
    Smith, Victoria
    Eckard, Sterling
    Guenot, Jeanmarie
    Chun, Patrick
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [29] PHASE 1 STUDY EVALUATING THE SAFETY AND PHARMACOKINETICS OF PANITUMUMAB IN CHILDREN WITH SOLID TUMORS
    Weigel, Brenda
    Banerjee, Anuradha
    Meany, Holly
    Malempati, Suman
    Fangusaro, Jason
    Zhang, Ying
    Ou, Ying
    Hoang, Tien
    Meyers, Paul
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S67 - S67
  • [30] Phase 1 open-label study evaluating pharmacokinetics, safety, and tolerability of linifanib in Japanese patients with solid tumors
    Tamura, Tomohide
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Yamada, Yasuhide
    Asahina, Hajime
    Shibata, Takashi
    Goto, Yasushi
    Tanioka, Maki
    Tamura, Yosuke
    Seki, Yoshitaka
    Chiu, Yi-Lin
    Gupta, Neeraj
    Carlson, Dawn
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
12345